Clinical Trials Browser

Completed × Adenocarcinoma × Leucovorin × Clear all

Adenocarcinoma, Rectal Neoplasms

NCT03777813 2025-11-18

ARION

Phase 2 Completed

112 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT04299880 2023-11-08

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

Phase 1 Completed

7 enrolled

Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Neoplasms, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pancreatic Neoplasms

Clinical Trials

NOAHS-ARC

ARION

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma

Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases

FOLFOX-D

MEGA

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

FABLOx

FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer

CatuNeo

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

HerFLOT

Phase I FOLFOX Combination

Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination